Evgen Pharma Plc (EVG)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Evgen Pharma Plc (EVG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013382
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Evgen Pharma Plc (Evgen Pharma), formerly Evgen Pharma Ltd is a drug discovery company that develops medicines to treat cancer and neurological diseases. The company uses sulforadex technology that synthesizes and concurrently stabilizes the naturally occurring compound such as sulforaphane. It carries out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. Evgen Pharma also undertakes clinical plans in oncology in patients with ER+ metastatic breast cancer. The company’s SFX-01 is a patented composition of the synthetic sulforaphane and alpha-cyclodextrin and has completed phase I clinical trials, and others. Evgen Pharma is headquartered in Wilmslow, the UK.

Evgen Pharma Plc (EVG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Evgen Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Evgen Pharma Raises USD3.1 Million Financing 10
Evgen Raises US$0.72 Million In Series B Financing 11
Evgen Secures Series A Financing 12
Licensing Agreements 13
Evgen Pharma Exercises Option for Licensing Agreement with CSIC and University of Seville 13
Evgen Exercises Option for Licensing Agreement with PharmAgra and Lalilab for Sulforade 14
Equity Offering 15
Evgen Pharma Raises USD11 Million in IPO 15
Evgen Pharma Plc – Key Competitors 16
Evgen Pharma Plc – Key Employees 17
Evgen Pharma Plc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Jun 13, 2017: Evgen Pharma Announces Final Results for the year ended 31 March 2017 19
Dec 05, 2016: Evgen Pharma: Interim results for the six months ended 30 September 2016 20
May 31, 2016: Evgen Pharma Announces Final Results for the year ended 31 March 2016 21
Corporate Communications 25
Apr 03, 2017: Evgen Pharma Announces Directorate Change 25
Jan 17, 2017: Evgen Pharma: Appointment of CFO and Head of Clinical Operations 26
Jan 04, 2016: Evgen Pharma Appoints Chief Medical Officer 27
Clinical Trials 28
Sep 15, 2016: Update re SFX-01 Data at ECTRIMS 2016 28
Sep 08, 2016: Evgen Pharma Announces Presentation of SFX-01 Data at ECTRIMS 2016 29
Aug 24, 2016: Evgen Pharma Announces Orphan Designation in the USA in Subarachnoid Haemorrhage 30
Aug 17, 2016: Evgen Pharma: Clinical Trial Approval for Phase II Study in Breast Cancer 31
May 03, 2016: Evgen Pharma: First Patient Dosed in Phase II Clinical Trial in SAH 33
Mar 02, 2016: Approval of Phase II Clinical Trial in SAH 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Evgen Pharma Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Evgen Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Evgen Pharma Plc, Deals By Therapy Area, 2011 to YTD 2017 8
Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Evgen Pharma Raises USD3.1 Million Financing 10
Evgen Raises US$0.72 Million In Series B Financing 11
Evgen Secures Series A Financing 12
Evgen Pharma Exercises Option for Licensing Agreement with CSIC and University of Seville 13
Evgen Exercises Option for Licensing Agreement with PharmAgra and Lalilab for Sulforade 14
Evgen Pharma Raises USD11 Million in IPO 15
Evgen Pharma Plc, Key Competitors 16
Evgen Pharma Plc, Key Employees 17
Evgen Pharma Plc, Other Locations 18

★海外企業調査レポート[Evgen Pharma Plc (EVG)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Applied DNA Sciences Inc (APDN):企業の財務・戦略的SWOT分析
    Summary Applied DNA Sciences Inc (APDN) is a biotechnology company that provides DNA based security and authentication solutions and services. The company offers products such as DNA security tools, DNA marking kit for assets and valuables, test kits, intruder and offender tagging systems; custom DN …
  • Termas De Puyehue S.A.:企業の戦略・SWOT・財務分析
    Termas De Puyehue S.A. - Strategy, SWOT and Corporate Finance Report Summary Termas De Puyehue S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • NanoViricides Inc (NNVC)-製薬・医療分野:企業M&A・提携分析
    Summary NanoViricides Inc (NanoViricides), formerly Edot-com.com Inc is a biopharmaceutical company that provides nanomedicine technology solutions. The company conducts research in the areas of medical science and pharmaceutical technology such as polymeric micelles, multi-specific multi-targeting, …
  • AGCO Corporation:企業の戦略・SWOT・財務分析
    AGCO Corporation - Strategy, SWOT and Corporate Finance Report Summary AGCO Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Ernst & Young Global Ltd:戦略・SWOT・企業財務分析
    Ernst & Young Global Ltd - Strategy, SWOT and Corporate Finance Report Summary Ernst & Young Global Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Logicalis Group Ltd:企業の戦略的SWOT分析
    Logicalis Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • ALS Ltd (ALQ):企業の財務・戦略的SWOT分析
    ALS Ltd (ALQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Corning Incorporated:企業の戦略・SWOT・財務情報
    Corning Incorporated - Strategy, SWOT and Corporate Finance Report Summary Corning Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • McDonald’s Australia Limited:企業の戦略的SWOT分析
    McDonald's Australia Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Esselte Corporation:企業の戦略・SWOT・財務分析
    Esselte Corporation - Strategy, SWOT and Corporate Finance Report Summary Esselte Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • RiceBran Technologies (RIBT):企業の財務・戦略的SWOT分析
    RiceBran Technologies (RIBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Odfjell Drilling Ltd (ODL):企業の財務・戦略的SWOT分析
    Odfjell Drilling Ltd (ODL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • PT. Indonesia Power:企業の発電所・SWOT分析2018
    PT. Indonesia Power - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • OJSC AK BARS Bank:企業の戦略・SWOT・財務情報
    OJSC AK BARS Bank - Strategy, SWOT and Corporate Finance Report Summary OJSC AK BARS Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sujana Universal Industries Ltd. (SUJANAUNI):企業の財務・戦略的SWOT分析
    Sujana Universal Industries Ltd. (SUJANAUNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Flint Group SA:企業の戦略的SWOT分析
    Flint Group SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Cadence Design Systems, Inc. (CDNS):企業の財務・戦略的SWOT分析
    Cadence Design Systems, Inc. (CDNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Beiersdorf AG (BEI):企業の財務・戦略的SWOT分析
    Beiersdorf AG (BEI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Manz AG (M5Z):電力:M&Aディール及び事業提携情報
    Summary Manz AG (Manz) is a manufacturer of high-technology equipment. It produces displays, printed circuit boards and other components for electronic devices. The company provides production equipment for lithium-ion battery cells, super capacitors, battery systems, and capacitors. Manz offers ind …
  • Samsung Biologics Co Ltd (207940):製薬・医療:M&Aディール及び事業提携情報
    Summary Samsung Biologics Co Ltd (Samsung Biologics) is a biologics development and manufacturing company. The company’s business activities include process development, contract manufacturing, aseptic fill and finish and project management. Samsung Biologics cell culture development process include …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆